scholarly article | Q13442814 |
P356 | DOI | 10.1111/AJT.13021 |
P8608 | Fatcat ID | release_n226n6jvfbgonkqbbcnxafqy5a |
P698 | PubMed publication ID | 25648447 |
P50 | author | David Baran | Q51529459 |
Mark J. Zucker | Q67298300 | ||
P2093 | author name string | A Jaiswal | |
I Sabnani | |||
P2860 | cites work | Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction | Q48490665 |
Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies. | Q51938333 | ||
Posterior leukoencephalopathy syndrome | Q24669598 | ||
A reversible posterior leukoencephalopathy syndrome | Q28273132 | ||
Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed | Q30982510 | ||
Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer | Q33259892 | ||
Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features | Q33324816 | ||
A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome | Q37234206 | ||
Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes | Q42553965 | ||
Reversible encephalopathy associated with tacrolimus in pediatric renal transplants | Q43683274 | ||
Posterior reversible encephalopathy syndrome after solid organ transplantation | Q45149439 | ||
Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings | Q46989268 | ||
Dexamethasone-induced posterior reversible encephalopathy syndrome | Q48142626 | ||
Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. | Q48348700 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | posterior reversible encephalopathy syndrome | Q7234232 |
P304 | page(s) | 823-826 | |
P577 | publication date | 2015-02-03 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | A unique case of rituximab-related posterior reversible encephalopathy syndrome in a heart transplant recipient with posttransplant lymphoproliferative disorder. | |
P478 | volume | 15 |